Skip to main content
. 2020 Apr 22;17(4):e1003095. doi: 10.1371/journal.pmed.1003095

Table 3. Number of patients with adjudicated clinical events.

Adjudicated clinical event Febuxostat (n = 241) Control (n = 247)
Total, number (%) 9 (3.7) 16 (6.5)
    Cardiovascular death 1 (0.4) 3 (1.2)
    Nonfatal myocardial infarction 0 (0.0) 1 (0.4)
    Nonfatal stroke 3 (1.2) 5 (2.0)
    Composite renal eventsa 3 (1.2) 4 (1.6)
    Non-cardiovascular death 2 (0.8) 4 (1.6)
    All-cause death 3 (1.2) 7 (2.8)

aComposite of doubling of serum creatinine, initiation of hemodialysis, and renal transplantation.